Ovid Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $43.6M | $72.0M |
| FY2021 | — | $179.7M | $187.8M |
| FY2022 | — | $132.3M | $44.9M |
| FY2023 | — | $87.8M | $27.0M |
| FY2024 | — | $68.2M | $26.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $43.6M | $72.0M |
| FY2021 | — | $179.7M | $187.8M |
| FY2022 | — | $132.3M | $44.9M |
| FY2023 | — | $87.8M | $27.0M |
| FY2024 | — | $68.2M | $26.3M |